Fragasso Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.53M Buy
4,609
+43
+0.9% +$43.9K 0.29% 37
2026
Q1
$4.23M Buy
4,566
+48
+1% +$48.7K 0.26% 42
2025
Q4
$4.86M Sell
4,518
-152
-3% -$145K 0.29% 34
2025
Q3
$3.92M Sell
4,670
-80
-2% -$59.5K 0.24% 40
2025
Q2
$3.7M Sell
4,750
-52
-1% -$40.4K 0.25% 44
2025
Q1
$3.97M Buy
4,802
+588
+14% +$489K 0.29% 42
2024
Q4
$3.25M Sell
4,214
-186
-4% -$154K 0.25% 57
2024
Q3
$3.9M Sell
4,400
-343
-7% -$308K 0.3% 53
2024
Q2
$4.29M Sell
4,743
-2,539
-35% -$2.03M 0.35% 45
2024
Q1
$5.66M Buy
7,282
+108
+2% +$76.9K 0.48% 35
2023
Q4
$4.18M Sell
7,174
-820
-10% -$479K 0.38% 50
2023
Q3
$4.29M Buy
7,994
+923
+13% +$476K 0.45% 33
2023
Q2
$3.32M Buy
7,071
+6,445
+1,030% +$2.7M 0.35% 51
2023
Q1
$215K Buy
626
+2
+0.3% +$675 0.02% 203
2022
Q4
$228K Hold
624
0.03% 191
2022
Q3
$202K Buy
624
+1
+0.2% +$317 0.03% 173
2022
Q2
$202K Buy
+623
New +$187K 0.03% 180

Other funds holding LLY

Fragasso Financial Advisors's LLY Position: Q2 2026 in Review

Fragasso Financial Advisors increased its Eli Lilly (LLY) stake by 0.94% in Q2 2026, buying an estimated $43.9K and bringing the position to 4,609 shares worth $5.53M. The position accounts for 0.29% of the portfolio, ranked #37.

Fragasso Financial Advisors first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.66M in Q1 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fragasso Financial Advisors held 4,609 shares of Eli Lilly worth $5.53M as of Q2 2026.
  • Fragasso Financial Advisors bought 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
  • Eli Lilly made up 0.29% of Fragasso Financial Advisors's portfolio in Q2 2026, its #37 holding.
  • Fragasso Financial Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • Fragasso Financial Advisors's Eli Lilly position peaked at $5.66M in Q1 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.